Chino Hills, CA, July 17, 2018 (GLOBE NEWSWIRE) -- SOHM, Inc. (PINKSHEETS: SHMN) a globally-known generic pharmaceutical manufacturer, release its first Qtr of 2018.
- YEAR END 2016 12 months ended Dec 2016 TOTAL REVENUE $124,261; GROSS PROFIT $94,006
- YEAR END 2017 12 months ended Dec 2017 TOTAL REVENUE $173,955; GROSS PROFIT $103,366
- 3 Months Ended March 2018 TOTAL REVENUE $180,837; GROSS PROFIT $95,292
SOHM, Inc.’s Annual Financial for year ending 2016, 2017 and First Qtr 2018 Sohm, Inc.’s Annual Financial for year ending 2016, 2017 and first qtr. which is ended on March 31, 2018. We are glad that we have now released all financials. We also thank all our shareholders for support and patience and as we reiterate management is working towards more actions and determined to update progress in a timely manner moving forward and especially for financials.
About SOHM, Inc.
SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a global presence and marketing plan that assure continuous growth. SOHM manufacturing and marketing target the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing in India as well as strategic alliance with US manufacturing facilities. Although SOHM’s generic pharmaceuticals are exported globally and was introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia. To know more about SOHM, Inc., visit www.SOHM.com
Safe Harbor Statement: This news release contains “forward-looking statements”, which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on for the most recent fiscal year, our quarterly reports uploaded from time-to-time on OTCMarkets.com.
For more information, please contact: SOHM, Inc. 714-522-6700
